Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies.
As immunization programs world-wide "mature" with high vaccine coverage and near elimination of vaccine-preventable disease, vaccine safety issues have increased in relative prominence. In the wake of events of 11 September 2001, fear of bioterrorism has reemerged. The paradigm of eradicating vaccine-preventable diseases, stopping vaccinations and thereby also eradicating the associated vaccine adverse events (a la smallpox) may unfortunately be obsolete. If all vaccinations have to be continued indefinitely, research is needed more than ever to understand and prevent rare vaccine adverse events. Case-control studies are usually best suited for such purposes, especially when nested within a pre-existing large-linked administrative database cohort to minimize bias. The new clinical immunization safety assessment centers may play an important role in bridging the sometimes conflicting clinical and epidemiologic perspectives in vaccine safety.
Chen
Robert T
RT
Immunization Safety Branch, National Immunization Program (MS-E61) Centers for Disease Control, Prevention Corporate Square Office Park, Building 12-Rm 2419 CDC, Atlanta, GA 30333, USA. bchen@cdc.gov
D016022:Case-Control Studies; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D006801:Humans; D007114:Immunization; D008004:Licensure; D011358:Product Surveillance, Postmarketing; D023481:Terrorism; D014612:Vaccines / Q000009:adverse effects* / Q000592:standards
D014612:Vaccines